1. Stein M, Hirshberg A. Medical consequences of terrorism. Surg Clin North Am. 1999;79:1537–1552. doi: 10.1016/S0039-6109(05)70091-8. [PubMed] [Cross Ref]
2. Mothershead JL. The new threat: weapons of mass effect. In: McGlown KJ, editor. Terrorism and disaster management: preparing healthcare leaders for the new reality. Chicago: Health Administration Press; 2004. pp. 27–48.
3. Bureau of Public Affairs, United States Department of State. Patterns of global terrorism. Washington, DC: Department of State; 2009.
4. Tucker JB. Scourge: the once and future threat of smallpox. New York: Atlantic Monthly Press; 2001.
5. Stearn EW, Stearn AE. The effects of smallpox on the density of the Amerindian. Boston: Bruce Humphries; 1945.
6. Ciraulo DL, Frykberg ER, Feliciano DV, Knuth TE, Richart CM, Westmoreland CD, et al. A survey assessment of the level of preparedness for domestic terrorism and mass casualty incidents among eastern association for the surgery of trauma members. J Trauma. 2004;56:1033–1041. doi: 10.1097/01.TA.0000127771.06138.7D. [PubMed] [Cross Ref] 7. Braum BI, Wineman NV, Finn NL, Barbera JA, Schmaltz SP, Loeb JM. Integrating hospitals into community emergency preparedness planning. Ann Intern Med. 2006;144:799–811. [PubMed]
8. Fenner F, Wittek R, Dumbell KR. The Orthopox viruses. San Diego: Academic Press; 1989. p. 432.
9. Henderson DA, Inglesby TV, Bartlett JG, Ashcer MS, Eitzen E, Jarhrling PB, et al. Smallpox as a biological weapon. In: Henderson DA, Inglesby TV, O’Toole T, et al., editors. Bioterrorism: guidelines for medical and public health management. Chicago: AMA Press; 2002. pp. 99–120.
10. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization; 1988. p. 1460.
11. Chapin CV, Smith J. Permanency of the mild type of smallpox. J Prev Med. 1932;1:1–29.
12. Fenner F, Wittek R, Dumbell KR. The Orthopox viruses. San Diego: Academic Press; 1989. p. 434.
13. Mack TM. Smallpox in Europe, 1950–71. J Infect Dis. 1972;125:161–169. doi: 10.1093/infdis/125.2.161. [PubMed] [Cross Ref] 14. Mack TM, Thomas DB, Khan MM. Epidemiology of smallpox in West Pakistan, II: determinants of intravillage spread other than acquired immunity. Am J Epidemiol. 1972;95:157–168. [PubMed]
15. Dixon CW. Smallpox. London: J & A Churchill Ltd.; 1962. p. 1460.
16. Wehrie PF, Posch J, Richter KH. An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe. Bull World Health Org. 1970;43:669–679. [PubMed]
17. Huggins JW, Bray M, Smee DF. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Geneva: WHO Advisory Committee on Variola Virus Research; 2001.
18. Koplan J, Monsur KA, Foster SO. Treatment of variola major with adenine arabinoside. J Infect Dis. 1975;131:34–39. doi: 10.1093/infdis/131.1.34. [PubMed] [Cross Ref]
19. Alibek K. Biohzard. New York: Random House Inc.; 1999.
20. Kim-Farley RJ, Celentano JT, Gunter C, Jones JW, Stone RA, Aller RD, et al. Standardized emergency management system and response to a smallpox emergency. Prehosp Disaster Med. 2003;18(4):313–320. [PubMed]
21. Margolskee D. Improving vaccines, antimicrobials, and antitoxins through research. In: Levy BS, Sidel VW, editors. Terrorism and public health: a balanced approach to strengthening systems and protecting people. Oxford University Press, Oxford; 2003. pp. 286–304.
22. Hull HF, Danila R, Ehresmann K. Smallpox and bioterrorism: public health responses. J Lab Clin Med. 2003;142(4):221–228. doi: 10.1016/S0022-2143(03)00144-6. [PubMed] [Cross Ref] 23. Nishiura H. Analysis of a previous smallpox vaccination study: estimation of the time period required to acquire vaccine-induced immunity as assessed by the revaccination. Southeast Asian J Trop Med Public Health. 2006;37(4):673–680. [PubMed] 24. Behbehani AM, Blower S. The smallpox story: life and death of an old disease. Microbiol Rev. 1983;47(4):455–509. [PMC free article] [PubMed]
25. Hopkins DR. Princes and peasants. Chicago: University of Chicago Press; 1983.
26. Brachman PS. The public health response to the anthrax epidemic. In: Levy BS, Sidel VW, editors. Terrorism and public health: a balanced approach to strengthening systems and protecting people. Oxford University Press, Oxford; 2003. pp. 101–17.
27. Heymann DL. Smallpox containment updated: considerations for the 21st century. Int J Infect Dis. 2004;8(suppl. 2):S15–S20. [PubMed]
28. World Health Organization. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication. Geneva: WHO; 1980.
29. Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine. 2005;23:2078–2081. doi: 10.1016/j.vaccine.2005.01.012. [PubMed] [Cross Ref]
30. Sternberg S. Scientists call for smallpox revaccination campaign. USA Today. 2002; December 23, p. 39.
31. Lindley M, Wortley PM, Winston C, Schwartz B. Programmatic factors related to smallpox vaccine update by healthcare workers and others. Infect Control Hosp Epidemiol. 2006;27:1242–1245. doi: 10.1086/508834. [PubMed] [Cross Ref]
32. Altman LK. Panel rules out smallpox shots for all. New York Times. 2002; June 21, p. A16.
33. Centers for Disease Control and Prevention, Office of Communications. Smallpox vaccination program status by State. Atlanta: CDC; 2005.
34. Downie AW, McCarthy K. The antibody response in man following infection with viruses of the pox group, III: antibody response in smallpox. J Hyg. 1958;56:479–487. doi: 10.1017/S0022172400037980. [PMC free article] [PubMed] [Cross Ref] 35. El-Ad R, Roth Y, Winder A. The presence of neutralizing antibodies after revaccination against smallpox. J Infect Dis. 1990;161:446–448. doi: 10.1093/infdis/161.3.446. [PubMed] [Cross Ref]
36. McClain DJ. Smallpox. In: Sidell FR, Takafuji E, Franz DR, editors. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington, DC: Borden Institute, Walter Reed Army Medical Center; 1997. pp. 539–59.
37. Blendon RJ, DesRoches CM, Benson JM, Herrmann MJ, Taylor-Clark K, Weldon KJ. The public and the smallpox vaccination: a national survey of emergency health care providers. N Engl J Med. 2003;348:426–432. doi: 10.1056/NEJMsa023184. [PubMed] [Cross Ref] 38. Wortley PM, Levy PS, Quick L, Shoemaker TR, Dahlke MA, Evans B, Burke B, Schwartz B. Predictors of smallpox vaccination among healthcare workers and other first responders. Am J Prev Med. 2007;32(6):538–541. doi: 10.1016/j.amepre.2007.02.002. [PubMed] [Cross Ref] 39. Ault A. US smallpox vaccine programme stalls as volunteers balk. Lancet. 2003;361:1626. doi: 10.1016/S0140-6736(03)13318-1. [PubMed] [Cross Ref] 40. Wortley PM, Schwartz B, Levy PS, Quick LM, Evans B, Burke B. Healthcare workers who elected not to receive smallpox vaccination. Am J Prev Med. 2006;30(3):258–265. doi: 10.1016/j.amepre.2005.10.005. [PubMed] [Cross Ref] 41. Yih WK, Lieu TA, Rego VH, O’Brian MA, Shay MA, Yokoe DS. Attitudes of healthcare workers in US hospitals regarding smallpox vaccination. BMC Public Health. 2003;3:20–28. doi: 10.1186/1471-2458-3-20. [PMC free article] [PubMed] [Cross Ref] 42. Sato H, Tomio J, Tanaka Y, Iwasaki E. The public acceptance of smallpox vaccination to fight bioterrorism in Japan: results of a large-scale opinion survey in Japan. Environ Health Prev Med. 2010. doi:10.1007/s12199-010-0199-1. [PMC free article] [PubMed] 43. Heiner GG, Fatima N, McCrumb FR. A study of intrafamilial transmission of smallpox. Am J Epidemiol. 1971;94:316–326. [PubMed] 44. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346:1300–1308. doi: 10.1056/NEJMra020025. [PubMed] [Cross Ref] 45. Dixon CW. Tripolitania, 1946: an epidemiological and clinical study of 500 cases, including trials of penicillin treatment. J Hyg. 1948;46:351–377. doi: 10.1017/S0022172400036536. [PMC free article] [PubMed] [Cross Ref]
46. Centers of Disease Control and Prevention. Interim smallpox response plans and guidelines. Atlanta: CDC; 2001.
47. Kretzchmar M, Hof S, Wallinga J, Wijngaarden J. Ring vaccination and smallpox control. Emerg Infect Dis. 2004;10(5):832–841. [PMC free article] [PubMed] 48. Centers for Disease Control and Prevention Vaccinia (smallpox) vaccine, recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. Mortal Morb Wkly Rep. 2001;50:1–25. [PubMed]
49. Expert Panel on Pre-outbreak Management, Group for Infectious Diseases, Health Science Council, Ministry of Health, Labor and Welfare, Japan. Actions of Ministry of Health, labor and welfare against bioterrorism. Tokyo: MHLW; 2002.
50. Section for Tuberculosis and Infectious Diseases, Ministry of Health, labor and welfare, Japan. Tennento taio shishin (Smallpox management plan), 5th ed. Tokyo: MHLW; 2004.
51. Noji EK. Public health aspects of weapons of mass destruction. In: McGlown KJ, editor. Terrorism and disaster management: preparing healthcare leaders for the new reality. Chicago: Health Administration Press; 2004. pp. 177–196.
52. Wittek R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis. 2006;10:193–201. doi: 10.1016/j.ijid.2005.12.001. [PubMed] [Cross Ref]
53. Sidel VW, Levy BS. Biological weapons. In: Levy BS, Sidel VW, editors. Terrorism and public health: a balanced approach to strengthening systems and protecting people. Oxford University Press, Oxford; 2003. pp. 175–98.
54. Poland GA, Grabenstein JD, Neff JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine. 2005;23(17–18):2078–2081. doi: 10.1016/j.vaccine.2005.01.012. [PubMed] [Cross Ref] 55. Fillmore GL, Ward TP, Bower KS, Dudenhoefer EJ, Grabenstein JD, Berry GK, et al. Ocular complications in the Department of Defense smallpox vaccination program. Ophthalmology. 2004;111:2086–2093. doi: 10.1016/j.ophtha.2004.04.027. [PubMed] [Cross Ref] 56. Klevens RM, Kupronis BA, Lawton R, Joseph D, Richards C. Monitoring health care workers after smallpox vaccination: findings from the hospital smallpox vaccination-monitoring system. Am J Infect Control. 2005;33:315–319. doi: 10.1016/j.ajic.2005.01.007. [PubMed] [Cross Ref] 57. Muralles AA, Ray P, Black S, Shinefield H, Casey C, Campbell S, Chen R. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine. 2006;24:476–484. doi: 10.1016/j.vaccine.2005.07.089. [PubMed] [Cross Ref] 58. Eckart RE, Love SS, Atwood E, Arness MK, Cassimatis DC, Campbell CL, et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol. 2004;44:201–205. doi: 10.1016/j.jacc.2004.05.004. [PubMed] [Cross Ref] 59. Lewis FS, Norton SA, Bradshaw RD, Lapa J, Grabenstein JD. Analysis of cases reported as generalized vaccinia during the US military smallpox vaccination program, December 2002 to December 2004. J Am Acad Dermatol. 2006;55:23–31. doi: 10.1016/j.jaad.2006.04.017. [PubMed] [Cross Ref]
60. Ray CG. Poxviruses. In: Ryan KJ, Ray CG, editors. Sherris medical microbiology. 4. New York: McGraw Hill; 2004. pp. 525–528.
61. Lane JM, Goldstein J. Adverse events occurring after smallpox vaccination. Sem Pediatr Infect Dis. 2003;14(3):189–195. doi: 10.1016/S1045-1870(03)00032-3. [PubMed] [Cross Ref] 62. Kretzcshmar M, Wallinga J, Teunis P, Xing S, Mikolajczyk R. Frequency of adverse events after vaccination with different vaccinia strains. PloS Medicine. 2006;3(8):e272. doi: 10.1371/journal.pmed.0030272. [PMC free article] [PubMed] [Cross Ref] 63. Auckland C, Cowlishaw A, Morgan D, Miller E. Reactions to smallpox vaccine in naive and previously vaccinated individuals. Vaccine. 2005;23:4185–4187. doi: 10.1016/j.vaccine.2004.10.052. [PubMed] [Cross Ref]
64. Hirayama M. Progress of research on attenuated smallpox vaccine in Japan. J Pediatr Infect Dis Immunol (Jpn Soc for Pediatr Infect Dis) 2008;20(1):65–71.
65. Hashizume S. Development of the attenuated smallpox vaccine, LC16m8, produced by cell culture. Modern Media. 2004;50(2):28–33.
66. Centers for Disease Control and Prevention. CDC interim guidance for revaccination of eligible persons who participated in the US Civilian Smallpox Preparedness and Response Program. Atlanta: CDC; 2008.
67. Henderson DA, Moss B. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadelphia: WB Saunders; 1999. pp. 74–97.
68. Hopkins RJ, Lane MJ. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin Infect Dis. 2004;39:819–826. doi: 10.1086/422999. [PubMed] [Cross Ref] 69. Napolitano PG, Ryan MAK, Grabenstein JD. Pregnancy discovered after smallpox vaccination: is vaccinia immune globulin appropriate? Am J Obstet Gynecol. 2004;191:1863–1867. doi: 10.1016/j.ajog.2004.07.014. [PubMed] [Cross Ref] 70. Nell P, Kohl KS, Graham PL, LaRussa PS, Marcy SM, Fulginiti VA, et al. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5735–5744. doi: 10.1016/j.vaccine.2007.02.088. [PubMed] [Cross Ref] 71. Thorne CD, Hirshon JM, Himes CD, McDiarmid MA. Emergency medicine tools to manage smallpox (vaccinia) vaccination complications: clinical practice guideline and policies and procedures. Ann Emerg Med. 2003;42(5):665–680. doi: 10.1016/S0196-0644(03)00629-2. [PubMed] [Cross Ref] 72. Fauci A. Smallpox vaccination policy: the need for dialogue. N Engl J Med. 2002;346:1319–1320. [PubMed] 73. Bicknell WJ. The case for voluntary smallpox vaccination. N Engl J Med. 2002;346:1323–1325. [PubMed] 74. Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ. Adverse events associated with smallpox vaccination in the United States, January–October 2003. JAMA. 2005;294:2734–2743. doi: 10.1001/jama.294.21.2734. [PubMed] [Cross Ref] 75. Malone JD. Pre-event smallpox vaccination for healthcare workers revisited—the need for a carefully screened multidisciplinary cadre. Int J Infect Dis. 2006;11:93–97. doi: 10.1016/j.ijid.2006.11.005. [PubMed] [Cross Ref]
76. Parkman PD, Hardegree MC. Regulation and testing of vaccines. In: Plotkin SA, Orenstein WA, editors. vaccines. Philadelphia: WB Saunders; 1999. pp. 1131–1143.
77. Section for Tuberculosis and Infectious Diseases, Ministry of Health, Labor and Welfare, Japan. Guidelines on smallpox vaccination. Tokyo: MHLW, 2004.
78. Senate Government Affairs Permanent Subcommittee on Investigations. Global Proliferation of Weapons of Mass Destruction: a case study on the Aum Shinrikyo, October 31, 1995. Washington, DC: FAS, 2001.
79. Barbera J, Macintyre A, Goston L, Inglesby TV, O’Toole T, DeAtley C, et al. Large-scale quarantine following biological terrorism in the United States. In: Henderson DA, Inglesby TV, O’Toole T, et al., editors. Bioterrorism: guidelines for medical and public health management. Chicago: AMA Press; 2002. pp. 221–232.
80. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. In: Henderson DA, Inglesby TV, O’Toole T, editors. Bioterrorism: guidelines for medical and public health management. Chicago: AMA Press; 2001. pp. 29–32.
81. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. Mortal Morb Wkly Rep. 2000; 47 (RR-15).
82. Centers for Disease Control and Prevention. Public Health’s Infrastructure: a status report. Prepared for the Appropriations Committee of the United States Senate, 2000. Atlanta: CDC, 2001.
83. Centers for Disease Control and Prevention. Protecting Americans: smallpox vaccination program. Atlanta: CDC, 2002.
84. Wayland WR, Brant MH. Legal and ethical considerations in disaster situations. In: McGlown KJ, editor. Terrorism and disaster management: preparing healthcare leaders for the new reality. Chicago: Health Administration Press; 2004. pp. 231–253.
85. Mothershead JL. Disaster planning for terrorism. In: McGlown KJ, editor. Terrorism and disaster management: preparing healthcare leaders for the new reality. Chicago: Health Administration Press; 2004. pp. 51–80.
86. Atchison CG, Uden-Holman T, Greene BR, Prybil LD. Developing the academic institution’s role in response to bioterrorism: the Iowa Center for Public Health Preparedness. J Public Health Manage Pract. 2003;9(5):418–426. [PubMed] 87. Balch D, Taylor C, Rosenthal D, Bausch C, Warner D, Morris R. Shadow Bowl 2003: A collaborative exercise in community readiness, agency cooperation, and medical response. Telemed J e-Health. 2004;10(3):330–342. doi: 10.1089/tmj.2004.10.330. [PubMed] [Cross Ref]
88. Heinrich J. Infectious disease outbreaks: Bioterrorism preparedness efforts have improved public health response capacity, but gaps remain Testimony before the Committee on Government Reform, House of Representatives. Washington, DC: Government Accountability Office; 2003.
89. Endo Y. Preparedness of medical facilities in the event of large-scale infectious disease epidemics. Koshu Eisei. 2007;71(6):523–528.